Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.
Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
Total published articles |
123 | 107 | 59 | 61 | 45 | 23 |
Research, Review articles and Editorials |
44 | 54 | 37 | 40 | 21 | 22 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
5 | 1 | 2 | 5 | 3 | 0 |
Conference proceedings |
6 | 16 | 5 | 7 | 0 | 45 |
Citations received as per Google Scholar, other indexing platforms and portals |
632 | 946 | 1156 | 1199 | 1039 | 1106 |
| Journal total citations count | 10648 |
| Journal impact factor | 12.50 |
| Journal 5 years impact factor | 18.23 |
| Journal cite score | 23.62 |
| Journal h-index | 43 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal citescore |
| Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Abdullah-Al-Mamun M, Al Azad S, Mondal KJ, Quazi S, Bonny SM, et al. (2016) FACTORIAL ANALYSIS OF THE REASONS OF TYPE 2 DIABETES MELLITUS FROM THE SELECTED URBAN AND RURAL SUBJECTS OF BANGLADESH. |
|
Khan S, Harikumar SL, Navis S. Diabetic Neuropathy: Current Pharmacological Management. |
|
Leeanansaksiri W, Rattananinsruang P, Dechsukhum C (2016) Human Embryonic Stem Cells and Induced Pluripotent Stem Cells: The Promising Tools for Insulin-Producing Cell Generation. InPluripotent Stem Cells-From the Bench to the Clinic 2016. InTech. |
|
Bener A, Al-Hamaq AO (2016) Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar. Experimental and Clinical Endocrinology & Diabetes 124: 504-511. |
|
Al-Rasheedi AA (2015) Glycemic control among patients with type 2 diabetes mellitus in countries of Arabic Gulf. International journal of health sciences 9: 345. |
|
Nwafor A, Mmom FC, Obia O, Obiandu C, Hart VO, et al. (2015) Relationship between Blood Pressure, Blood Glucose and Body Mass Index and Coexisting Prehypertension and Prediabetes among Rural Adults in Niger Delta Region, Nigeria. British Journal of Medicine and Medical Research 9. |
|
El-Menyar A, Al-Thani H, Mekkodathil A, Mohammed S, Singh R, et al. (2015) Diabetes mellitus in patients presenting with cardiovascular events: Descriptive analysis from a tertiary heart hospital over a 22-year period. Current vascular pharmacology 13: 624-636. |
|
Wang RH, Hsu HC, Lee YJ, Shin SJ, Lin KD, et al. (2016) Patient empowerment interacts with health literacy to associate with subsequent self-management behaviors in patients with type 2 diabetes: A prospective study in Taiwan. Patient education and counseling 99:1626-1631. |
|
Chaudhry WN, Badar R, Jamal M, Jeong J, Zafar J, et al. (2016) Clinico‑microbiological study and antibiotic resistance profile of mecA and ESBL gene prevalence in patients with diabetic foot infections. Experimental and therapeutic medicine 11: 1031-1038. |
|
Bener A, Kim EJ, Mutlu F, Eliyan A, Delghan H, et al. (2014) Burden of diabetes mellitus attributable to demographic levels in Qatar: An emerging public health problem. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 8: 216-220. |
|
Lee YJ, Shin SJ, Wang RH, Lin KD, Lee YL, et al. (2016) Pathways of empowerment perceptions, health literacy, self-efficacy, and self-care behaviors to glycemic control in patients with type 2 diabetes mellitus. Patient education and counseling 99: 287-294. |
|
Sajid Hamid Akash M, Rehman K, Chen S. Goto-Kakizaki rats: its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus. Current diabetes reviews. 2013 Sep 1;9(5):387-96. |
|
Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011 Dec 25;2(9):1000167. |
|
Vial G, Chauvin MA, Bendridi N, Durand A, Meugnier E, Madec AM, Bernoud-Hubac N, de Barros JP, Fontaine É, Acquaviva C, Hallakou-Bozec S. Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model. Diabetes. 2015 Jun 1;64(6):2254-64. |
|
Pirags V, Lebovitz H, Fouqueray P. Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients. Diabetes, Obesity and Metabolism. 2012 Sep;14(9):852-8. |
|
Pacini G, Mari A, Fouqueray P, Bolze S, Roden M. Imeglimin increases glucoseâ€dependent insulin secretion and improves βâ€cell function in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. 2015 Jun;17(6):541-5. |
|
Fouqueray P, Pirags V, Diamant M, Schernthaner G, Lebovitz HE, Inzucchi SE, Bailey CJ. The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy. Diabetes care. 2014 Jul 1;37(7):1924-30. |
|
Fouqueray P, Pirags V, Inzucchi SE, Bailey CJ, Schernthaner G, Diamant M, Lebovitz HE. The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy. Diabetes Care. 2013 Mar 1;36(3):565-8. |
|
Martineau LC. Simple thermodynamic model of unassisted proton shuttle uncoupling and prediction of activity from calculated speciation, lipophilicity, and molecular geometry. Journal of theoretical biology. 2012 Jun 21;303:33-61. |
|
Vuylsteke V, Chastain LM, Maggu GA, Brown C. Imeglimin: a potential new multi-target drug for type 2 diabetes. Drugs in R&D. 2015 Sep 1;15(3):227-32. |
|
